MAGEA6 and glioma: For example, MAGEA6-AMPK signaling is activated by knock-out IGF2BP1 with CRISPR/Cas9, resulting in the apoptosis of glioma cells (A172) and inhibiting the survival of human glioma cells, so as to achieve a therapeutic effect [108].